Neurocrine Biosciences
NBIX
#1441
Rank
S$20.61 B
Marketcap
S$202.77
Share price
-2.05%
Change (1 day)
27.49%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Quarterly Reports

Thumbnail Neurocrine Biosciences
 Quarterly Report 2026-q1

Quarterly Report 2026-q1

Language: English

View Quarterly Report
Thumbnail Neurocrine Biosciences
 Quarterly Report 2025-q3

Quarterly Report 2025-q3

Language: English

View Quarterly Report
Thumbnail Neurocrine Biosciences
 Quarterly Report 2025-q2

Quarterly Report 2025-q2

Language: English

View Quarterly Report
Thumbnail Neurocrine Biosciences
 Quarterly Report 2025-q1

Quarterly Report 2025-q1

Language: English

View Quarterly Report